LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP
Clinical trials for LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP explained in plain language.
Never miss a new study
Get alerted when new LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP trials appear
Sign up with your email to follow new studies for LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study checks if HIV prevention shots and contraceptives mix safely
Knowledge-focused Not yet recruitingThis study looks at how a long-acting injectable HIV prevention drug (CAB-LA) and hormonal birth control methods affect each other in women. About 105 women who already use CAB-LA or no HIV prevention will choose to use an injectable contraceptive, an implant, or no hormonal birt…
Matched conditions: LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 26, 2026 10:13 UTC
-
Malawi study tracks Women's HIV prevention choices to boost PrEP success
Knowledge-focused Not yet recruitingThis study looks at how women in Blantyre, Malawi choose and use HIV prevention pills (oral PrEP) or shots (injectable PrEP). Researchers will follow 384 women to see why some stop PrEP and how tracing them can help re-engage them in care. The goal is to improve HIV prevention pr…
Matched conditions: LONG-ACTING INJECTABLE CABOTEGRAVIR FOR PREP
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Knowledge-focused
Last updated May 26, 2026 10:11 UTC